Gameto

New York, United States

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

$44.0M raised

Aug 2025

Series C

Top Investors

Pontiva Healthcare PartnersInsight PartnersGaingelsRA Capital ManagementTwo Sigma Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Gameto raised?

Gameto has raised $44.0M in total funding. The most recent round was Series C. The last funding was announced in August 2025.

Who are Gameto's investors?

Gameto's investors include Pontiva Healthcare Partners, Insight Partners, Gaingels, RA Capital Management, Two Sigma Ventures.

Where is Gameto headquartered?

Gameto is headquartered in New York, United States.

What does Gameto do?

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

What stage is Gameto at?

Gameto is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 12, 2025.

MLA

"Gameto — Funding & Investors." VCBacked, August 12, 2025, https://www.vcbacked.co/company/gameto. Accessed June 4, 2026.

APA

VCBacked. (2025). Gameto — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/gameto

Wikipedia (cite web)

{{cite web |title=Gameto — Funding & Investors |url=https://www.vcbacked.co/company/gameto |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 12, 2025.